Primarily prescribed for type 2 diabetes and weight loss, medications like Ozempic and Zepbound are also showing promise in treating a range of other conditions, from sleep apnea to chronic kidney disease. Now, a new study published in JAMA Network Open suggests that for people with obesity and type 2 diabetes, these drugs—known as GLP-1…
Eating less protein may be linked to greater muscle loss for people taking weight loss drugs like Ozempic, according to a recent study presented July 12 at the ENDO 2025 conference, the Endocrine Society’s annual meeting. Rapid weight loss—regardless of how it’s achieved—is known to reduce lean mass, or muscle. Low muscle mass can increase…
A new medication called MariTide is showing promise for weight loss, according to results from a phase 2 clinical trial posted on June 23. People with obesity who took the drug, which is manufactured by Amgen, lost up to 16% of their body weight over 52 weeks. Among participants with both obesity and type 2…
A new study found that older adults with diabetes who were taking GLP-1s—a class of medications that have become popular for weight loss—had a higher risk of developing neovascular age-related macular degeneration (nAMD), an eye condition that can lead to blindness. “Notably, this risk appeared to increase with longer duration of exposure, representing a dose-response…
When Penny Gautreaux started taking Rybelsus, an oral version of semaglutide, it didn’t take long for some of the side effects her doctor had warned her about to hit. “I noticed stomach pain and gastrointestinal distress almost immediately,” said Gautreux, who began taking the medication in the spring of 2023 to manage her type 2…
A daily pill from Eli Lilly could be as effective for weight loss and blood sugar control as injections like Ozempic or Wegovy, according to April data from a Phase 3 clinical trial. The glucagon-like peptide-1 (GLP-1) oral medication, called orforglipron, would allow people to reap the benefits from these blockbuster weight loss drugs without…
